Australian Securities and Investments Commission, in the matter of Chemeq Limited (ACN 009 135 264) v Chemeq Limited (ACN 009 135 264) [2006] FCA 936

Australian Securities and Investments Commission, in the matter of Chemeq Limited (ACN 009 135 264) v Chemeq Limited (ACN 009 135 264) [2006] FCA 936

Chemeq contravened s 674(2) of the Corporations Act 2001 (Cth) by failing to notify the ASX of material cost increases in its production facility and the lack of commercial significance of a publicised US patent. The admitted contraventions justified pecuniary penalties at the levels proposed, due to the seriousness of non-disclosure, the necessity for deterrence, absence of dishonesty, changes in governance and compliance systems, and cooperation with the regulator.

Parties
Plaintiff; Cross Respondent: Australian Securities and Investments Commission; Defendant; Cross Claimant: Chemeq Limited (ACN 009 135 264)
Jurisdiction
Australia
Judgment Date
24 July 2006
Procedural Posture
Civil Penalty Proceeding / Judgment After Admissions, Orders Imposed
Outcome
Declarations made; penalties imposed; costs awarded; cross-claim dismissed
Legal Topics
Continuous Disclosure, Civil Penalties, Market Regulation, Corporate Governance
Corporations Law Securities Regulation Continuous Disclosure Civil Penalties Market Regulation Corporate Governance

Case Brief

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Full judgment text Downloadable case file Legal principles 3 Authorities cited 9 Party arguments 2 Amounts and remedies 12
Sign in to unlock

Parties

Australian Securities and Investments Commission

Plaintiff; Cross Respondent

Chemeq Limited (ACN 009 135 264)

Defendant; Cross Claimant

Procedural Posture

Civil Penalty Proceeding / Judgment After Admissions, Orders Imposed

Legal Issues

  1. 1 Whether Chemeq contravened s 674(2) of the Corporations Act 2001 (Cth) by failing to disclose material information to the ASX regarding cost increases and patent significance
  2. 2 What penalties are appropriate for admitted contraventions of continuous disclosure obligations

Ratio Decidendi

Chemeq contravened s 674(2) of the Corporations Act 2001 (Cth) by failing to notify the ASX of material cost increases in its production facility and the lack of commercial significance of a publicised US patent. The admitted contraventions justified pecuniary penalties at the levels proposed, due to the seriousness of non-disclosure, the necessity for deterrence, absence of dishonesty, changes in governance and compliance systems, and cooperation with the regulator.

Court Disposition

Declarations made; penalties imposed; costs awarded; cross-claim dismissed

Orders

  • Declaration that Chemeq contravened s 674(2) of the Corporations Act 2001 (Cth) by non-disclosure of Rockingham facility cost increases.
  • Declaration that Chemeq contravened s 674(2) by non-disclosure of the lack of commercial significance of the US patent.